Biblio
2019
Kok, L.M.C., Bungener, L., de Bock, G.H., Biswana, A., van der Wal, G., van Imhoff, G.W., and Bellido, M. (2019).
Risk factors associated with the development of moderate to severe chronic graft-versus-host disease after non-myeloablative conditioning allogeneic stem cell transplantation in patients with AML or MDS.Hum Cell.
Lugtenburg, P.J., Zijlstra, J.M., Doorduijn, J.K., Böhmer, L.H., Hoogendoorn, M., Berenschot, H.W., Beeker, A., de Graauw, N.C. van der, Schouten, H.C., Bilgin, Y.M., et al. (2019).
Rituximab-PECC induction followed by Y-ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT: results from a phase II HOVON study.Br J Haematol.
2015
Poire, X., Labopin, M., Cornelissen, J.J., Volin, L., Espiga, C.Richard, J Veelken, H., Milpied, N., Cahn, J.-Y., Yacoub-Agha, I., van Imhoff, G.W., et al. (2015).
Outcome of conditioning intensity in acute myeloid leukemia with monosomal karyotype in patients over 45 year-old: A study from the Acute Leukemia Working Party (ALWP) of the European group of Blood and Marrow Transplantation (EBMT).Am J Hematol.
]